{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:04:02Z","timestamp":1789513442453,"version":"build-2803163510"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clnu.2026.106741","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:35:13Z","timestamp":1785220513000},"page":"106741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Long-term antithrombotic therapy in patients with short bowel syndrome: A European Society for Clinical Nutrition and Metabolism (ESPEN) position paper"],"prefix":"10.1016","volume":"64","author":[{"given":"Deleenheer","family":"B","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlin","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"N","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coppens","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corcos","family":"O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuerda","family":"C","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douketis","family":"J","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppesen","family":"PB","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joly","family":"F","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lal","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamprecht","family":"G","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meade","family":"U","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mundi","family":"M","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pironi","family":"L","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szczepanek","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanassche","family":"T","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Gossum","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanten","family":"G","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van der Linden","family":"L","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-0903","authenticated-orcid":false,"given":"Vanuytsel","family":"T","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.clnu.2026.106741_bib1","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.clnu.2023.07.019","article-title":"ESPEN guideline on chronic intestinal failure in adults - update 2023","volume":"42","author":"Pironi","year":"2023","journal-title":"Clin Nutr Oct"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00068-016-0634-0","article-title":"ESTES guidelines: acute mesenteric ischaemia","volume":"42","author":"Tilsed","year":"2016","journal-title":"Eur J Trauma Emerg Surg Apr"},{"issue":"1","key":"10.1016\/j.clnu.2026.106741_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13017-022-00443-x","article-title":"Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery","volume":"17","author":"Bala","year":"2022","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.clnu.2026.106741_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ejvs.2017.01.010","article-title":"Editor\u2019s Choice - Management of the diseases of mesenteric arteries and Veins: clinical Practice Guidelines of the European Society of vascular surgery (ESVS)","volume":"4","author":"Bj\u00f6rck","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/2050640620916681","volume":"8","author":"Terlouw","year":"2020","journal-title":"United European Gastroenterol J May"},{"key":"10.1016\/j.clnu.2026.106741_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.intf.2024.100007","article-title":"Anticoagulation and antiplatelet therapy in short bowel syndrome: a systematic review","volume":"1","author":"Mercer","year":"2024","journal-title":"Intestinal Failure"},{"key":"10.1016\/j.clnu.2026.106741_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.clnesp.2025.07.1126","article-title":"Long-term antithrombotic therapy practices in adult patients with short bowel syndrome following acute mesenteric ischemia: an international case-based survey","volume":"69","author":"Deleenheer","year":"2025","journal-title":"Clin Nutr ESPEN"},{"issue":"7","key":"10.1016\/j.clnu.2026.106741_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/eurjcn\/zvab059","article-title":"Coming to consensus: the Delphi technique","volume":"20","author":"Niederberger","year":"2021","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib9","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.sla.0000154269.52294.57","article-title":"Clinical implications for the management of acute thromboembolic occlusion of the superior mesenteric artery: autopsy findings in 213 patients","volume":"241","author":"Acosta","year":"2005","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1067\/mva.2002.120373","article-title":"Contemporary management of acute mesenteric ischemia: factors associated with survival","volume":"35","author":"Park","year":"2002","journal-title":"J Vasc Surg Mar"},{"issue":"36","key":"10.1016\/j.clnu.2026.106741_bib11","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J Sep 29"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib12","article-title":"European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin","volume":"7","author":"Rubiera","year":"2022","journal-title":"Eur Stroke J Sep"},{"issue":"7","key":"10.1016\/j.clnu.2026.106741_bib13","first-page":"e364","article-title":"2021 Guideline for the prevention of stroke in patients With stroke and transient ischemic attack: a Guideline From the American heart Association\/American stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke Jul"},{"issue":"1","key":"10.1016\/j.clnu.2026.106741_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2015.09.011","article-title":"Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism","volume":"29","author":"Saric","year":"2016","journal-title":"J Am Soc Echocardiogr Jan"},{"issue":"22","key":"10.1016\/j.clnu.2026.106741_bib15","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1182\/bloodadvances.2023010177","article-title":"American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing","volume":"7","author":"Middeldorp","year":"2023","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.clnu.2026.106741_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5694\/mja2.50004","article-title":"New guidelines from the Thrombosis and Haemostasis Society of Australia and New Zealand for the diagnosis and management of venous thromboembolism","volume":"210","author":"Tran","year":"2019","journal-title":"Med J Aust Mar"},{"key":"10.1016\/j.clnu.2026.106741_bib17","series-title":"Venous thromboembolic diseases: diagnosis, management and thrombophilia testing","year":"2023"},{"issue":"10","key":"10.1016\/j.clnu.2026.106741_bib18","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.clnu.2026.106741_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jacc.2022.10.008","article-title":"Direct oral anticoagulants vs vitamin K antagonists in patients With antiphospholipid syndromes: Meta-Analysis of randomized trials","volume":"81","author":"Khairani","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/bjh.19635","article-title":"Guidelines on the investigation and management of antiphospholipid syndrome","volume":"205","author":"Arachchillage","year":"2024","journal-title":"Br J Haematol Sep"},{"issue":"6","key":"10.1016\/j.clnu.2026.106741_bib21","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: Second Update of the CHEST Guideline and expert Panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest Dec"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11239-015-1197-3","article-title":"Thrombophilia: clinical-practical aspects","volume":"39","author":"Moll","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"10.1016\/j.clnu.2026.106741_bib23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/jth.14846","article-title":"Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Tripodi","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.clnu.2026.106741_bib24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/jth.12265","article-title":"Thrombotic complications of myeloproliferative neoplasms: risk assessment and risk-guided management","volume":"11","author":"Casini","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"25","key":"10.1016\/j.clnu.2026.106741_bib25","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11239-015-1171-0","article-title":"Managing unusual presentations of venous thromboembolism","volume":"39","author":"Ageno","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2009.02.004","article-title":"Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review","volume":"124","author":"Lussana","year":"2009","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.clnu.2026.106741_bib28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients With liver disease: 2020 practice guidance by the American Association for the Study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology Jan"},{"issue":"5","key":"10.1016\/j.clnu.2026.106741_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clnu.2026.106741_bib30","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/ueg2.12744","article-title":"Incidence and management of splanchnic vein thrombosis in pancreatic diseases","volume":"13","author":"Borb\u00e9ly","year":"2025","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.clnu.2026.106741_bib31","first-page":"763","volume":"2018","author":"Aboyans","year":"2017","journal-title":"Eur Heart J"},{"issue":"36","key":"10.1016\/j.clnu.2026.106741_bib32","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J Sep 29"},{"issue":"5","key":"10.1016\/j.clnu.2026.106741_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ejvs.2023.03.042","article-title":"Editor\u2019s Choice - European Society for vascular surgery (ESVS) 2023 Clinical Practice Guidelines on antithrombotic therapy for vascular diseases","volume":"65","author":"Twine","year":"2023","journal-title":"Eur J Vasc Endovasc Surg May"},{"issue":"38","key":"10.1016\/j.clnu.2026.106741_bib34","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.clnu.2026.106741_bib35","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.119.040631","article-title":"Assessment and treatment of patients With type 2 myocardial infarction and acute nonischemic myocardial injury","volume":"140","author":"DeFilippis","year":"2019","journal-title":"Circulation"},{"issue":"34","key":"10.1016\/j.clnu.2026.106741_bib36","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"10.1016\/j.clnu.2026.106741_bib37","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest Feb"},{"issue":"7","key":"10.1016\/j.clnu.2026.106741_bib38","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/jth.14836","article-title":"Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation","volume":"18","author":"Di Nisio","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.clnu.2026.106741_bib39","doi-asserted-by":"crossref","DOI":"10.1080\/17425255.2023.2256216","article-title":"Drug absorption from oral formulations in patients with short bowel syndrome: a comprehensive update of the literature","author":"Azuz","year":"2023","journal-title":"Expert opinion on drug metabolism & toxicology"},{"issue":"14","key":"10.1016\/j.clnu.2026.106741_bib40","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2165\/00003088-200443140-00001","article-title":"Enteral drug absorption in patients with short small bowel : a review","volume":"43","author":"Severijnen","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.clnu.2026.106741_bib41","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s11605-009-1151-9","article-title":"The impact of intestinal failure on oral drug absorption: a review","volume":"14","author":"Ward","year":"2010","journal-title":"J Gastrointest Surg"},{"issue":"12","key":"10.1016\/j.clnu.2026.106741_bib42","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00228-018-2539-9","article-title":"Systematic review of drug bioavailability following gastrointestinal surgery","volume":"74","author":"Santamar\u00eda","year":"2018","journal-title":"Eur J Clin Pharmacol Dec"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s13318-021-00696-y","article-title":"Changes of drug pharmacokinetics in patients with short bowel syndrome: a systematic review. Review","volume":"46","author":"Hong","year":"2021","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jphp.12928","article-title":"Impact of gastrointestinal disease states on oral drug absorption - implications for formulation design - a PEARRL review","volume":"71","author":"Effinger","year":"2019","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1016\/j.clnu.2026.106741_bib45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jpen.1767","article-title":"Effect of Glepaglutide, a long-acting glucagon-like Peptide-2 analog, on gastrointestinal transit time and motility in patients With short bowel syndrome: findings From a randomized trial. Article","volume":"44","author":"Hvistendahl","year":"2020","journal-title":"Journal of Parenteral and Enteral Nutrition"},{"issue":"12","key":"10.1016\/j.clnu.2026.106741_bib46","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2165\/00003088-200544120-00003","article-title":"Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol","volume":"44","author":"Ufer","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"2 Suppl","key":"10.1016\/j.clnu.2026.106741_bib47","doi-asserted-by":"crossref","first-page":"e152S","DOI":"10.1378\/chest.11-2295","article-title":"Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Holbrook","year":"2012","journal-title":"Chest Feb"},{"key":"10.1016\/j.clnu.2026.106741_bib48","unstructured":"Meade U, Shing R, Nightingale J, BIFACommittee. Predicting drug absorption in patients with a short bowel. BIFA (Specialist Interest Group of BAPEN). Accessed May 19 2025, https:\/\/www.bapen.org.uk\/pdfs\/bifa\/bifa-top-tips-series-18.pdf."},{"issue":"10","key":"10.1016\/j.clnu.2026.106741_bib49","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib50","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/jgh.13024","article-title":"Dabigatran-induced esophagitis: the prevalence and endoscopic characteristics","volume":"31","author":"Toya","year":"2016","journal-title":"J Gastroenterol Hepatol Mar"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10040137","article-title":"Pharmacological efficacy and gastrointestinal safety of different aspirin formulations for cardiovascular prevention: a narrative review","volume":"10","author":"Clerici","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"8","key":"10.1016\/j.clnu.2026.106741_bib52","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/17425255.2024.2386368","article-title":"Pharmacokinetics of aspirin: evaluating shortcomings in the literature","volume":"20","author":"Visagie","year":"2024","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"6","key":"10.1016\/j.clnu.2026.106741_bib53","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/1060028014526700","article-title":"Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome","volume":"48","author":"Faye","year":"2014","journal-title":"Ann Pharmacother"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib54","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","article-title":"Clinical pharmacokinetics and pharmacodynamics of clopidogrel","volume":"54","author":"Jiang","year":"2015","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.clnu.2026.106741_bib55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/cpdd.259","article-title":"The pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy Japanese volunteers","volume":"5","author":"Umemura","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"9","key":"10.1016\/j.clnu.2026.106741_bib56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.31083\/ph.2012.1754","article-title":"Pharmacokinetics of clopidogrel in healthy Chinese volunteers","volume":"67","author":"Zou","year":"2012","journal-title":"Pharmazie"},{"key":"10.1016\/j.clnu.2026.106741_bib57","article-title":"Pharmacokinetics of apixaban in patients with short bowel syndrome: a Bayesian re-estimation approach","volume":"29","author":"Hronov\u00e1","year":"2025","journal-title":"Expert Opin Drug Metab Toxicol Sep"},{"key":"10.1016\/j.clnu.2026.106741_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109398","article-title":"Absorption and anticoagulant management of rivaroxaban in patients with short bowel syndrome","volume":"253","author":"Lunau","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.clnu.2026.106741_bib59","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.thromres.2017.10.025","article-title":"Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: the PDER PAN study","volume":"160","author":"Cheung","year":"2017","journal-title":"Thromb Res Dec"},{"issue":"Suppl 1","key":"10.1016\/j.clnu.2026.106741_bib60","first-page":"849","article-title":"Rivaroxaban in patients with intestinal failure on parenteral nutrition (TINCRBEL study)","volume":"6","author":"van Haaps","year":"2022"},{"key":"10.1016\/j.clnu.2026.106741_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ehjcvp\/pvx017","article-title":"Aspirin wears smart","volume":"4","author":"Mollace","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib62","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1553-2712.2008.00318.x","article-title":"A comparison of salicylic acid levels in normal subjects after rectal versus oral dosing","volume":"16","author":"Maalouf","year":"2009","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.clnu.2026.106741_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205227","article-title":"Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting","author":"Droppa","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clnu.2026.106741_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202241","article-title":"Short bowel syndrome and clopidogrel non-responsiveness: a new indication for platelet aggregometry?","author":"Hadley","year":"2014","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib65","article-title":"Antiplatelet resistance: a review of concepts, mechanisms, and implications for management in acute ischemic stroke and transient ischemic attack","volume":"3","author":"Krishnan","year":"2023","journal-title":"Stroke: Vascular and Interventional Neurology May"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib66","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.chest.2024.03.003","article-title":"Antithrombotic therapy for VTE disease: Compendium and Review of CHEST Guidelines 2012-2021","volume":"166","author":"Stevens","year":"2024","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.clnu.2026.106741_bib67","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med Mar 30"},{"issue":"8","key":"10.1016\/j.clnu.2026.106741_bib68","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"10480","key":"10.1016\/j.clnu.2026.106741_bib69","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0140-6736(24)02842-3","article-title":"Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial","volume":"405","author":"Couturaud","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib70","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejvs.2025.06.010","article-title":"Editor\u2019s Choice - European Society for vascular surgery (ESVS) 2025 Clinical Practice Guidelines on the management of diseases of the mesenteric and renal arteries and veins","volume":"70","author":"Koelemay","year":"2025","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"10.1016\/j.clnu.2026.106741_bib71","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/hep.22772","article-title":"Vascular disorders of the liver","volume":"49","author":"DeLeve","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clnu.2026.106741_bib72","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejvs.2023.07.011","article-title":"A systematic review of endovascular repair outcomes in atherosclerotic chronic mesenteric ischaemia","volume":"66","author":"Nana","year":"2023","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.clnu.2026.106741_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jss.2024.11.018","article-title":"Outcome of single versus dual antiplatelet therapy After complex endovascular aortic repair","volume":"305","author":"Mulorz","year":"2025","journal-title":"J Surg Res"},{"issue":"14","key":"10.1016\/j.clnu.2026.106741_bib74","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.clnu.2026.106741_bib75","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med May 21"},{"issue":"1","key":"10.1016\/j.clnu.2026.106741_bib76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-9560-11-11","article-title":"Laboratory assessment of rivaroxaban: a review","volume":"11","author":"Samama","year":"2013","journal-title":"Thromb J"},{"issue":"19","key":"10.1016\/j.clnu.2026.106741_bib77","doi-asserted-by":"crossref","first-page":"e009807","DOI":"10.1161\/JAHA.118.009807","article-title":"Limitations of specific coagulation tests for direct oral anticoagulants: a critical analysis","volume":"7","author":"Ebner","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib78","doi-asserted-by":"crossref","first-page":"e200107","DOI":"10.1001\/jamanetworkopen.2020.0107","article-title":"Outcomes associated With oral anticoagulants Plus antiplatelets in patients With newly diagnosed atrial fibrillation","volume":"3","author":"Fox","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"Suppl A","key":"10.1016\/j.clnu.2026.106741_bib79","doi-asserted-by":"crossref","first-page":"A32","DOI":"10.1093\/eurheartj\/suab153","article-title":"The value and limitations of new oral anticoagulant plasma level assessments","volume":"24","author":"Van der Linden","year":"2022","journal-title":"Eur Heart J Suppl"},{"issue":"10","key":"10.1016\/j.clnu.2026.106741_bib80","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Review","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.clnu.2026.106741_bib81","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/a-1450-8178","article-title":"2021 update of the International Council for standardization in haematology recommendations for laboratory measurement of direct oral anticoagulants","volume":"121","author":"Douxfils","year":"2021","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.clnu.2026.106741_bib82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1055\/a-2446-1348","article-title":"Usual On-therapy ranges of drug concentrations in patients with atrial fibrillation treated with direct oral anticoagulants: a systematic review and Meta-analysis","volume":"125","author":"de Vries","year":"2025","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib83","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.clnu.2026.106741_bib84","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1182\/bloodadvances.2018024893","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy","volume":"2","author":"Witt","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.clnu.2026.106741_bib85","doi-asserted-by":"crossref","first-page":"105","DOI":"10.36518\/2689-0216.1464","article-title":"Anti-Factor Xa level monitoring for enoxaparin prophylaxis and treatment in high-risk patient groups","volume":"4","author":"Sikes","year":"2023","journal-title":"HCA Healthc J Med"},{"issue":"4","key":"10.1016\/j.clnu.2026.106741_bib86","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/jcpt.13169","article-title":"The effect of anti-Xa monitoring on the safety and efficacy of low-molecular-weight heparin anticoagulation therapy: a systematic review and meta-analysis","volume":"45","author":"Wu","year":"2020","journal-title":"J Clin Pharm Ther"},{"issue":"12","key":"10.1016\/j.clnu.2026.106741_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9123907","article-title":"Effectiveness of platelet function analysis-guided aspirin and\/or clopidogrel therapy in preventing secondary stroke: a systematic review and meta-analysis","volume":"9","author":"Yan","year":"2020","journal-title":"J Clin Med"},{"issue":"10","key":"10.1016\/j.clnu.2026.106741_bib88","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1007\/s00415-020-09932-y","article-title":"Platelet function\/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis","volume":"267","author":"Lim","year":"2020","journal-title":"J Neurol"},{"issue":"5","key":"10.1016\/j.clnu.2026.106741_bib89","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/jth.12527","article-title":"Catheter-associated deep vein thrombosis of the upper extremity in cancer patients: guidance from the SSC of the ISTH","volume":"12","author":"Zwicker","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib90","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jtha.2023.11.017","article-title":"Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"14","key":"10.1016\/j.clnu.2026.106741_bib91","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2416112","article-title":"Extended reduced-dose apixaban for cancer-associated venous thromboembolism","volume":"392","author":"Mah\u00e9","year":"2025","journal-title":"N Engl J Med Apr 10"},{"issue":"7","key":"10.1016\/j.clnu.2026.106741_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071816","article-title":"Research progress on the mechanism of nanoparticles crossing the intestinal epithelial cell membrane","volume":"15","author":"He","year":"2023","journal-title":"Pharmaceutics"},{"issue":"12","key":"10.1016\/j.clnu.2026.106741_bib93","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/17425255.2023.2287472","article-title":"Pharmacokinetics and pharmacodynamics of direct oral anticoagulants","volume":"19","author":"Hindley","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clnu.2026.106741_bib94","first-page":"419","article-title":"Insufficient anticoagulation with dabigatran in a patient with short bowel syndrome","volume":"2","author":"Douros","year":"2014","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib95","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.thromres.2015.01.005","article-title":"Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases","volume":"135","author":"Christensen","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.clnu.2026.106741_bib96","unstructured":"Bavalia R MR, Serlie MJM, Middeldorp S, Coppens M. Interim analysis-safety and efficacy of rivaroxaban in a patient population with short bowel syndrome; a prospective observational cohort study."},{"issue":"3","key":"10.1016\/j.clnu.2026.106741_bib97","first-page":"342.e17","article-title":"Personalized anticoagulation: guided apixaban Dose adjustment to compensate for pharmacokinetic abnormalities related to short-bowel syndrome","volume":"34","author":"Pollak","year":"2018","journal-title":"Can J Cardiol"},{"issue":"24","key":"10.1016\/j.clnu.2026.106741_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13247757","article-title":"Role of antiplatelets and anticoagulation therapies in pregnancy","volume":"13","author":"Zachariah","year":"2024","journal-title":"J Clin Med"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561426001688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:40:44Z","timestamp":1789512044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561426001688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":98,"alternative-id":["S0261561426001688"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106741","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term antithrombotic therapy in patients with short bowel syndrome: A European Society for Clinical Nutrition and Metabolism (ESPEN) position paper","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2026.106741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106741"}}